कृपया अन्य खोज का प्रयास करें
TMS Co., Ltd. engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities. The company is developing TMS-007, a stachybotrys microspora triprenyl phenol (SMTP) congener with prothrombolytic and anti-inflammatory/antioxidative activities, which has completed Phase 2a clinical trials for acute ischemic stroke treatment; and TMS-008, an SMTP congener with anti-inflammatory/antioxidative activities under nonclinical development for inflammatory complications, such as acute kidney injury and cancer cachexia. It is also developing TMS-009, a product candidate in preclinical development. The company has a collaboration with Hokkaido University and Kanazawa University to evaluate the potential of the drug candidate compounds as novel drugs, as well as a joint research agreement with Teikyo University to identify biomarkers for renal function and a strategic alliance with Ji Xing Pharmaceuticals Limited. TMS Co., Ltd. was incorporated in 2005 and is headquartered in Fuchu, Japan.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Kazuo Honda | - | - | Statutory Auditor |
Kenichi Nakamura | - | - | Statutory Auditor |
Hiroyuki Hasegawa | - | - | Statutory Auditor |
Takuro Wakabayashi | 57 | 2011 | President & Representative Director |
Ken Takanashi | 60 | 2020 | Independent Outside Director |
Reiko Namikawa | 71 | 2021 | Independent Outside Director |
Tsuyoshi Ito | 54 | 2018 | Director & CFO |
Noriaki Inamura | 69 | 2015 | Executive Vice President of Development & Director |
Keiji Hasumi | 67 | 2005 | Founder, Chief Scientific Officer & Chairman |
Nobuaki Kobayashi | 70 | 2021 | Chairman of Corporate Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है